MeSH term
Frequency | Condition_Probility | Animals | 29 | 0.0 |
Aortic Aneurysm/surgery | 2 | 13.0 |
Bioprosthesis/standards | 2 | 15.0 |
Equipment Failure | 2 | 8.0 |
Heart Valve Diseases/pathology/surgery | 2 | 15.0 |
Heart Valve Prosthesis/*standards | 2 | 15.0 |
Humans | 42 | 0.0 |
Postoperative Complications/etiology | 2 | 5.0 |
Prosthesis Design | 2 | 4.0 |
*Stents | 2 | 3.0 |
Swine | 2 | 0.0 |
3T3 Cells | 4 | 0.0 |
Carrier Proteins/genetics/*metabolism | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 8 | 0.0 |
Endoplasmic Reticulum/*metabolism/ultrastructure | 2 | 25.0 |
Golgi Apparatus/*metabolism/ultrastructure | 2 | 13.0 |
*Heat-Shock Proteins | 8 | 12.0 |
Hela Cells | 13 | 0.0 |
Mice | 11 | 0.0 |
Molecular Chaperones/genetics/*metabolism | 2 | 10.0 |
Mutation/genetics | 3 | 0.0 |
Protein Folding | 10 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 17 | 0.0 |
Transcription Factors/genetics/*metabolism | 7 | 0.0 |
Carrier Proteins/*metabolism | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 9 | 0.0 |
Molecular Chaperones/*metabolism | 3 | 5.0 |
*Protein Folding | 8 | 6.0 |
Transcription Factors/*metabolism | 10 | 0.0 |
Endoplasmic Reticulum/genetics/*metabolism | 2 | 100.0 |
Gene Expression Regulation | 5 | 0.0 |
Phosphorylation | 4 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Blotting, Western | 4 | 0.0 |
COS Cells | 4 | 0.0 |
Cell Line | 11 | 0.0 |
Cell Nucleus/metabolism | 6 | 0.0 |
Endoplasmic Reticulum/metabolism | 6 | 2.0 |
Genes, Dominant | 2 | 0.0 |
Genes, Reporter | 4 | 0.0 |
Models, Biological | 3 | 0.0 |
Mutation | 7 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Signal Transduction | 6 | 0.0 |
Time Factors | 2 | 0.0 |
Trans-Activation (Genetics) | 3 | 0.0 |
Transfection | 10 | 0.0 |
Leucine Zippers | 3 | 1.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Protein Denaturation | 4 | 1.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 20 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Tunicamycin/pharmacology | 4 | 5.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
Mice, Knockout | 4 | 0.0 |
Transcription Factors/metabolism | 3 | 0.0 |
eIF-2 Kinase/metabolism | 2 | 14.0 |
CHO Cells | 4 | 0.0 |
Consensus Sequence | 2 | 0.0 |
Cricetulus | 2 | 0.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Hamsters | 4 | 0.0 |
RNA Splicing | 2 | 0.0 |
Transcription Factors/*physiology | 2 | 0.0 |
Endoplasmic Reticulum/*metabolism | 16 | 11.0 |
Hydrolysis | 3 | 0.0 |
Protein Transport | 2 | 0.0 |
Base Sequence | 7 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Saccharomyces cerevisiae | 3 | 1.0 |
Transcription Factors/*genetics/*metabolism | 2 | 1.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Protein Binding | 6 | 0.0 |
Membrane Proteins/genetics/*metabolism | 2 | 0.0 |
Protease Inhibitors/pharmacology | 2 | 0.0 |
DNA-Binding Proteins/physiology | 3 | 1.0 |
Homeostasis | 3 | 0.0 |
Apoptosis | 3 | 0.0 |
Calcium/metabolism | 2 | 0.0 |
Glycosylation | 4 | 0.0 |
Membrane Proteins/chemistry/metabolism | 2 | 6.0 |
Molecular Chaperones/genetics | 4 | 18.0 |
Cercopithecus aethiops | 3 | 0.0 |
Endoplasmic Reticulum/drug effects/*metabolism | 2 | 25.0 |
NIH 3T3 Cells | 2 | 0.0 |
Amino Acid Sequence | 7 | 0.0 |
Nuclear Proteins/*metabolism | 3 | 0.0 |
Point Mutation | 2 | 0.0 |
Binding Sites | 5 | 0.0 |
Golgi Apparatus/metabolism | 3 | 1.0 |
Immunoblotting | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Serine Endopeptidases/*chemistry | 2 | 22.0 |
Amino Acid Motifs | 2 | 0.0 |
Carrier Proteins/metabolism | 2 | 0.0 |
Molecular Chaperones/metabolism | 4 | 8.0 |
*Proprotein Convertases | 2 | 13.0 |
Sequence Alignment | 2 | 0.0 |
Thapsigargin/pharmacology | 3 | 2.0 |
Transcription Factors/chemistry/genetics/*metabolism | 2 | 1.0 |
DNA-Binding Proteins/chemistry/*metabolism | 2 | 1.0 |
Oxidative Stress | 2 | 0.0 |
Transcription Factors/chemistry/*metabolism | 2 | 1.0 |
Cloning, Molecular | 2 | 0.0 |
DNA | 2 | 0.0 |
Carrier Proteins/genetics | 2 | 0.0 |
Mutagenesis | 2 | 0.0 |
Membrane Proteins/*metabolism | 2 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 3 | 0.0 |
Heat-Shock Proteins/metabolism | 2 | 3.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Dithiothreitol/pharmacology | 2 | 2.0 |
Enzyme Inhibitors/metabolism | 2 | 0.0 |